Leukotriene receptor antagonists are ineffective for severe atopic dermatitis
- 31 March 2004
- journal article
- other
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 50 (3) , 485-486
- https://doi.org/10.1016/s0190-9622(03)00758-8
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitisJournal of the American Academy of Dermatology, 2001
- The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis.Archives of Dermatology, 1998
- Summary of Clinical Trials with ZafirlukastAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Montelukast for Chronic Asthma in 6- to 14-Year-Old ChildrenJAMA, 1998
- The leukotriene D4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis.American Journal of Respiratory and Critical Care Medicine, 1995
- LEUKOTRIENES IN SKIN OF ATOPIC DERMATITISThe Lancet, 1984